GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (HKSE:02359) » Definitions » FFO

Wuxi AppTec Co (HKSE:02359) FFO


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co FFO?

FFO (Funds from operations) only applies to REITs.


Wuxi AppTec Co Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, gene therapies, and testing services for medical devices. Its segments comprise WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It generates the majority of its revenue from the WuXi Chemistry segment. Its geographic areas are the PRC, USA, Europe, and the Rest of the world, in which it generates the majority of its revenue from the USA.
Executives
Jpmorgan Chase & Co.
Blackrock, Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.
Brown Brothers Harriman & Co. 2502 Approved lending agent
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Computershare Hong Kong Trustees Limited 2301 Trustee
Bank Of America Corporation
Hsbc Holdings Plc 2201 Interest of corporation controlled by you
Qatar Investment Authority
Al Rayyan Holding Llc